With the arrival of Lilly’s Kisunla, Alzheimer’s care could become more like treatment of cancer and rheumatoid arthritis and their regular infusions.
Related Posts
Novo Nordisk Launches Wegovy Weight-Loss Drug in China
The first prescription for the drug in China will reportedly be issued at a public hospital in Shanghai this week and will cost about $193 […]
Novo Nordisk’s Wegovy Sales Beat Expectations
The pharmaceutical giant narrowed its full-year guidance after its blockbuster Wegovy weight-loss drug beat sales expectations in the third quarter.
Layoffs in 2024: A List of Companies Cutting Jobs This Year
The layoffs are expected to be smaller and more targeted than those in 2023.